Treatment Registry
TR-0838 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Renlo Health · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$269

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change.

Medication · Monthly · recorded initial monthly payment$269

Added from the figures recorded below.

Price

TermPer monthCharged today
MonthlyAdvertised

“Tirzepatide A once-weekly compounded tirzepatide injection, prescribed by a provider as part of a personalized treatment plan. $399 $269 /mo”

Per month$269Charged today$269
Price sources
Visit Renlo Health

We earn nothing from this link. It opens Renlo Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyVialsRx · TX · 503A
StatesAll 50 states
PrescriberAsynchronous review
CancellationBilled monthly. Cancel anytime, no fee.
MembershipNone. “Everything included Medication + injection supplies Provider evaluation + ongoing care Free expedited shipping Unlimited care-team messaging No membership or consultation fees”
Consult feeNone. “No membership or consultation fees. Billed monthly. Cancel anytime, no fee.”

Recorded from renlohealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Renlo names Arora Health & Aesthetics, LLC of 300 Lenora Street, Seattle, WA as its provider group and VialsRx of 6220 Westpark Dr, Houston, TX as its partner pharmacy. Idgie Health (idgiehealth.com) names the same pharmacy at the same address and states its service availability in the same words, sentence for sentence. A reader treating the two as independent options is not getting two.

1 further note concerns other Renlo Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0838
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Renlo Health

All Renlo Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Renlo Health — compounded tirzepatide (TR-0838). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0838

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.